Kura Sushi
2695
Nippon Telegraph & Telephone
9432
Metaplanet
3350
4
GFA
8783
5
Shiseido
4911
JP Stock MarketDetailed Quotes
4588 Oncolys BioPharma
- 660
- +27+4.27%
20min DelayMarket Closed Feb 20 15:30 JST
16.47BMarket Cap-6.06P/E (Static)
662High628Low699.20KVolume630Open633Pre Close454.53MTurnover91852wk High3.07%Turnover Ratio24.96MShares42052wk Low-95.72EPS TTM15.01BFloat Cap4410Historical HighLossP/E (Static)22.75MShs Float401Historical Low-108.92EPS LYR5.37%Amplitude--Dividend TTM11.58P/B100Lot Size--Div YieldTTM
About Oncolys BioPharma Company
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Company Profile
Symbol4588
Company NameOncolys BioPharma
Founded2004-03-18
MarketTSE Growth
Fiscal Year Ends12-31
Address4-1-28 Toranomon Toranomon Towers Office
Zip Code105-0001
Phone03-5472-1578
Websitewww.oncolys.com
Company Executives
- Name
- Position
- Salary
- Yasuo Urata
- President and Chief Executive Officer, Research and Development and CMC
- --
- Yasunari Katagihara
- Director of Business Development and Risk Management
- --
- Naoko Iino
- Independent Director
- --
- Yasushi Saitou
- Independent Director
- --